TRANSDIFFERENTIATION OF NEOPLASM

This adverse event was reported 58 times

These drugs are most commonly taken by patients reporting TRANSDIFFERENTIATION OF NEOPLASM:

# Drug Count
0 OXALIPLATIN 14
1 ETOPOSIDE 11
2 IMATINIB 11
3 FLUOROURACIL 10
4 FLUOROURACIL CREAM, 0.5% 10
5 DOCETAXEL 8
6 DOCETAXEL ANHYDROUS 8
7 CISPLATIN 7
8 CARBOPLATIN 6
9 IFOSFAMIDE 6
See all common drugs associated with TRANSDIFFERENTIATION OF NEOPLASM

TRANSDIFFERENTIATION OF NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LAROTRECTINIB 1 0.0011
1 ETHIODIZED OIL 1 0.0008
2 ESTROGEN 2 0.0007
3 BREXUCABTAGENE AUTOLEUCEL 1 0.0005
4 BLEOMYCIN SULFATE 4 0.0004
5 INOTUZUMAB OZOGAMICIN 1 0.0003
6 VINORELBINE 2 0.0003
7 IFOSFAMIDE FOR INJECTION 6 0.0003
8 ERLOTINIB HYDROCHLORIDE 3 0.0002
9 BICALUTAMIDE 3 0.0002
See all drugs enriched for association with TRANSDIFFERENTIATION OF NEOPLASM